热门资讯> 正文

RxSight任命新首席执行官

2026-07-16 04:18

RxSight(RXST) 0
Alcon(ALC) 0

RxSight (RXST) appointed Aziz Mottiwala as president and chief executive officer, effective July 20, 2026.
Mottiwala succeeds Ron Kurtz, M.D., who will remain with the company as chief medical officer.
Mottiwala most recently served as chief commercial officer at Tarsus Pharmaceuticals.

More on RxSight

RxSight: After Dropping To The Bottom, It's Time To Pick It Up
RxSight: Alcon Deal Reshapes The Long-Term Growth Story
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight anticipates $140M to $160M 2026 revenue as Alcon collaboration adds $30M to $40M
Alcon collaborates with RxSight to develop adjustable PCIOLs

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。